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A57-year-old man with a history of idiopathic dilatedcardiomyopathy was admitted to HahnemannUniversity Hospital, Philadelphia, with progressivesymptoms of heart failure and was listed for heart
transplantation. His condition deteriorated despite institution of
inotropic drug support. An echocardiogram showed global biven-
tricular dysfunction with no aortic stenosis or insufficiency. On
June 20, 2000, a TCI VE HeartMate left ventricular assist system
(LVAS) (Thoratec Corporation, Pleasanton, Calif) was implanted.
The patient had an uneventful postoperative course and was dis-
charged to his home on July 23, 2000. He was doing well with
LVAS rates between 70 and 80 beats/min and flows ranging
between 6 and 8 L/min. Two and one-half months after implanta-
tion, he began to have mild dyspnea with his usual activities. The
LVAS rates and flows were inappropriately elevated at rest (80-100
beats/min, flows 8-9 L/min). An echocardiogram showed moderate
LVAS inflow valve regurgitation and mild native aortic valve insuf-
ficiency. On October 3, 2000, an orthotopic heart transplantation
was performed. The LVAS inflow valve had two small linear per-
forations in the leaflets and partial dehiscence of two commissures.
The LVAS outflow valve was intact. The aortic valve was fused
along the anterior aspect of the left noncoronary commissure
(Figure 1). The posterior aspect of the commissure was open. A
small thrombus was present along the right lunula of the left coro-
nary cusp of the aortic valve. Examination of the ostium of the out-
flow graft insertion revealed it to be situated above the right coro-
nary cusp with the angle of the graft directed toward the left
coronary cusp. The ostia of the coronary arteries were patent. No
mineralization was noted. Microscopic examination of the valve
across the area of fusion revealed the fusion tissue to be composed
of myxomatous granulation tissue adherent to the inflow aspect of
the left and noncoronary cusps (Figure 1). No evidence of remote
endocarditis or of organizing thrombus at the point of fusion was
detected. The remainder of the valve cusps showed no evidence of
chronic rheumatic valve disease.
The patient recovered well and was discharged to his home on
October 13, 2000, with no shortness of breath.
Discussion
As the duration of support with implantable LVAS units is extended,
the issues regarding device durability and cardiac remodeling have
begun to surface. Issues of drive-line infection, controller malfunc-
tion, battery life span, and inflow valve integrity have raised concern
regarding current LVAS units as destination devices. A new problem
that has been recently recognized is acquired native aortic valve dis-
ease induced by long-term LVAS support.1
To our knowledge, the only report of acquired native aortic
valve disease associated with an implantable LVAS was by Rose
and colleagues1 from the University of Minnesota. In this report, 4
of 6 patients with the TCI Heartmate LVAS showed evidence of
commissural fusion at the time of explantation for transplantation.
The mechanism was believed to be thrombus formation, organiza-
tion, and subsequent acquired aortic stenosis. The mean duration
of LVAS support was 180 days, but there was no correlation
between the duration of LVAS implantation and the generation of
aortic valve thrombosis and commissural fusion. Furthermore,
there were no clinical signs suggestive of this process. 
In our case, the aortic valve disease was suggestive of “sys-
temic” pressure–related changes on the valve leaflets, particularly
those of the native aortic valve and the LVAS inflow valve (25 mm
porcine valve, Medtronic, Inc, Minneapolis, Minn). The findings
on the native valve were not present before the LVAS by echocar-
diography, so that the emergence of this abnormality can be con-
sidered an acquired phenomenon from the LVAS. The mechanism
of the inappropriately elevated rates and flows is related to the
recycling of blood into the left ventricular cavity through the insuf-
ficient valves combined with a lower resistance to LVAS flow.
As a result of this finding, we began to routinely use echocar-
diography to monitor patients with long-term (>6 months) LVAS
support, whether or not they had symptoms or demonstrated
inappropriately elevated LVAS rates and flows. Interestingly, 2
of 4 patients having long-term outpatient LVAS support had
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Addendum
Since the preparation of this report, 3 additional patients have
demonstrated inappropriately elevated LVAS rates and flows with
inflow valve and native aortic valve insufficiency. 
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inappropriately elevated rates and flows, 1 of whom admitted to
increased shortness of breath. The other 2 patients were symp-
tom-free with appropriate LVAS rates and flows. Echo-
cardiography in the patients with inappropriate rates and flows
showed mild to moderate degrees of LVAS inflow valve and
native aortic valve regurgitation. No native aortic or LVAS
inflow valve insufficiency was detected in the patients having
appropriate rates and flows.
From the clinicopathologic finding in the case report and the
observations of the remaining patients, we recommend a sur-
veillance strategy for patients requiring long-term support with
implantable LVAS units. Routine echocardiography should be
performed at 6-month intervals in the absence of symptoms to
document native aortic and LVAS inflow valve integrity. In the
presence of new symptoms (dyspnea) or inappropriately elevat-
ed LVAS rates and flows, echocardiography should be per-
formed to search for valve abnormalities.
Figure 2. Microscopic view of area of fusion between the left and
noncoronary cusps. Granulation tissue spans the space between
the two valve cusps causing adherence at the inflow surface.
Figure 1. Native aortic valve demonstrating fusion of the anterior
commissure between the left and noncoronary cusps. A small
thrombus is present on the right lunula of the left cusp.
